Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 14, 2018 - Issue
Submit an article Journal homepage
126
Views
2
CrossRef citations to date
0
Altmetric
Case Report

Aripiprazole combination for reversal of paliperidone-induced increase in prolactin level

Pu Zhi1 Department of Psychiatry, Xi’an Mental Health Center, Institute of Mental Health, Xi’an Medical University, Xi’an, China, [email protected]
,
Yanqiong Wang1 Department of Psychiatry, Xi’an Mental Health Center, Institute of Mental Health, Xi’an Medical University, Xi’an, China, [email protected]
,
Wei Quan1 Department of Psychiatry, Xi’an Mental Health Center, Institute of Mental Health, Xi’an Medical University, Xi’an, China, [email protected];2 Department of Natural Medicine, Institute of Materia Medica, School of Pharmacy, Fourth Military Medical University, Xi’an, China
,
Yanli Su1 Department of Psychiatry, Xi’an Mental Health Center, Institute of Mental Health, Xi’an Medical University, Xi’an, China, [email protected]
&
Hui Zhang1 Department of Psychiatry, Xi’an Mental Health Center, Institute of Mental Health, Xi’an Medical University, Xi’an, China, [email protected]Correspondence[email protected]
Pages 2175-2179 | Published online: 27 Aug 2018

References

  • RosenbloomALArlanLRCorrection: hyperprolactinemia with antipsychotic drugs in children and adolescentsInt J Pediatr Endocrinol2013201311323958460
  • SvestkaJSynekOTomanováJRodákováICejpkováADifferences in the effect of second-generation antipsychotics on prolactinaemia: six weeks open-label trial in female in-patientsNeuro Endocrinol Lett200728688188818063941
  • BostwickJRGuthrieSKEllingrodVLAntipsychotic-induced hyperprolactinemiaPharmacotherapy2009291647319113797
  • BlackWPGovanADLaparoscopy and ovarian biopsy for the assessment of secondary amenorrheaAm J Obstet Gynecol197211467397474267006
  • QiaoYYangFLiCAdd-on effects of a low-dose aripiprazole in resolving hyperprolactinemia induced by risperidone or paliperidonePsychiatry Res2016237838926921057
  • LiXTangYWangCAdjunctive aripiprazole versus placebo for antipsychotic-induced hyperprolactinemia: meta-analysis of randomized controlled trialsPLoS One201388e7017923936389
  • RainkaMMCapoteHARossCAGengoFMAttenuation of risperidone-induced hyperprolactinemia with the addition of aripiprazoleJ Clin Pharm Ther200934559559819744015
  • FitzgeraldPDinanTGProlactin and dopamine: what is the connection? A review articleJ Psychopharmacol2008222 Suppl121918477617
  • BroekhofRGosselinkMJPijlHGiltayEJThe effect of aripiprazole and quinagolide, a dopamine agonist, in a patient with symptomatic pituitary prolactinoma and chronic psychosisGen Hosp Psychiatry2012342209.e1e3
  • de BerardisDFornaroMSerroniNTreatment of antipsychotic-induced hyperprolactinemia: an update on the role of the dopaminergic receptors D2 partial agonist aripiprazoleRecent Pat Endocr Metab Immune Drug Discov201481303724372345
  • ChenJXSuYAWangSLAripiprazole treatment of risperidone-induced hyperprolactinemiaJ Clin Psychiatry20097071058105919653986
  • RaghuthamanGVenkateswaranRKrishnadasRAdjunctive aripiprazole in risperidone-induced hyperprolactinaemia: double-blind, randomised, placebo-controlled trialBJPsych Open20151217217727703744
  • ZhaoJSongXAiXAdjunctive aripiprazole treatment for risperidone-induced hyperprolactinemia: an 8-week randomized, open-label, comparative clinical trialPLoS One20151010e013971726448615
  • RanjbarFSadeghi-BazarganiHNiari KhamsPArfaieASalariAFarahbakhshMAdjunctive treatment with aripiprazole for risperidone-induced hyperprolactinemiaNeuropsychiatr Dis Treat20151154955525784810
  • CurranRLBadranIAPeppersVAripiprazole for the treatment of antipsychotic-induced hyperprolactinemia in an adolescent boyJ Child Adolesc Psychopharmacol201626549049127120681
  • KesslerRMAripiprazole: what is the role of dopamine D(2) receptor partial agonism?Am J Psychiatry200716491310131217728411
  • InoueTDomaeMYamadaKFurukawaTEffects of the novel antipsychotic agent 7-(4-[4-(2,3-dichlorophenyl)-1-piperazinyl] butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597) on prolactin release from the rat anterior pituitary glandJ Pharmacol Exp Ther199627711371438613910
  • ShinCHanCPaeCUPatkarAAPrecision medicine for psychopharmacology: a general introductionExpert Rev Neurother201616783183927104961
  • ZhaoJPShiSXPrevention guide to mental illness-Chinese Medical AssociationBeijingChin Med Electron Audio-Video Publis House2015183185
  • MauriMCVolonteriLSColasantiAFiorentiniAde GaspariIFBareggiSRClinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical responseClin Pharmacokinet200746535938817465637
  • XiaSYZhangYRYuHMengXZhangPLiuJTreatment of antipsychotic drug-induced phlegm dampness type amenorrhea by Wuji Powder and a small dose aripiprazole: a clinical studyChin J Integr Tradit West Med2014341214401443
  • DuttaURPonnalaRPiduguVKDalalABChromosomal abnormalities in amenorrhea: a retrospective study and review of 637 patients in South IndiaArch Iran Med201316526727023641739
  • RhodesSJDimattiaGERosenfeldMGTranscriptional mechanisms in anterior pituitary cell differentiationCurr Opin Genet Dev1994457097177849511
  • ShemankoCSProlactin receptor in breast cancer: marker for metastatic riskJ Mol Endocrinol2016574R153R16527658959

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.